Advertisement

First Edition

January 19, 2018

January 18, 2018

January 17, 2018

January 16, 2018

January 12, 2018

  • Minimal/measurable residual disease in AML: consensus document from ELN MRD Working Party
    Gerrit J. Schuurhuis, Michael Heuser, Sylvie Freeman, Marie-Christine Béné, Francesco Buccisano, Jacqueline Cloos, David Grimwade, Torsten Haferlach, Robert K. Hills, Christopher S. Hourigan, Jeffrey L. Jorgensen, Wolfgang Kern, Francis Lacombe, Luca Maurillo, Claude Preudhomme, Bert A. van der Reijden, Christian Thiede, Adriano Venditti, Paresh Vyas, Brent L. Wood, Roland B. Walter, Konstanze Döhner, Gail J. Roboz and Gert J. Ossenkoppele

January 11, 2018

January 10, 2018

January 09, 2018

  • Casein Kinase 1 is a Therapeutic Target in Chronic Lymphocytic Leukemia
    Pavlina Janovska, Jan Verner, Jiri Kohoutek, Lenka Bryjova, Michaela Gregorova, Marta Dzimkova, Hana Skabrahova, Tomasz Radaszkiewicz, Petra Ovesna, Olga Vondalova Blanarova, Tereza Nemcova, Zuzana Hoferova, Katerina Vasickova, Lucie Smyckova, Alexander Egle, Sarka Pavlova, Lucie Poppova, Karla Plevova, Sarka Pospisilova and Vitezslav Bryja
  • Targeting anticoagulant protein S to improve hemostasis in hemophilia
    Raja Prince, Luca Bologna, Mirko Manetti, Daniela Melchiorre, Irene Rosa, Natacha Dewarrat, Silvia Suardi, Poorya Amini, José A. Fernández, Laurent Burnier, Claudia Quarroz, Maria Desiré Reina Caro, Yasuhiro Matsumura, Johanna A. Kremer Hovinga, John H. Griffin, Hans-Uwe Simon, Lidia Ibba-Manneschi, François Saller, Sara Calzavarini and Anne Angelillo-Scherrer

January 08, 2018

January 05, 2018

  • ABO Zygosity, but not Secretor or Fc Receptor Status, is a Significant Risk Factor for IVIG-Associated Hemolysis
    Donald R. Branch, Åsa Hellberg, Christine W. Bruggeman, Jill R. Storry, Darinka Sakac, Megan Blacquiere, Tik Nga Tong, Emeralda Burke-Murphy, Beth Binnington, Nagina Parmar, Lorna Sampson Riden, Kezia Willie, Chantal Armali, Jiwajee Aziz, Lani Lieberman, Vincent Laroche, Jeannie Callum, Yulia Lin, Nadine Shehata, Katerina Pavenski, Wendy Lau, Barbara Hannach, Taco W. Kuijpers, Martin L Olsson, Christine Cserti-Gazdewich and Jacob Pendergrast
  • Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia (T-ALL)
    Karen L. Bride, Tiffaney L. Vincent, Soo-Yeon Im, Richard Aplenc, David M. Barrett, William L. Carroll, Robin Carson, Yunfeng Dai, Meenakshi Devidas, Kimberly P. Dunsmore, Tori Fuller, Tina Glisovic-Aplenc, Terzah M. Horton, Stephen P. Hunger, Mignon L. Loh, Shannon L. Maude, Elizabeth A. Raetz, Stuart S. Winter, Stephan A. Grupp, Michelle L. Hermiston, Brent L. Wood and David T. Teachey
  • Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy
    Steven Coutre, Michael Choi, Richard R. Furman, Herbert Eradat, Leonard Heffner, Jeffrey A. Jones, Brenda Chyla, Lang Zhou, Suresh Agarwal, Tina Waskiewicz, Maria Verdugo, Rod A. Humerickhouse, Jalaja Potluri, William G. Wierda and Matthew S. Davids

January 04, 2018

  • Copper-64-labeled daratumumab as a PET/CT imaging tracer for multiple myeloma
    Enrico Caserta, Junie Chea, Megan Minnix, Domenico Viola, Steven Vonderfecht, Paul Yazaki, Desiree Crow, Jihane Khalife, James F. Sanchez, Joycelynne M. Palmer, Susanta Hui, Nadia Carlesso, Jonathan Keats, Young Kim, Ralf Buettner, Guido Marcucci, Steven Rosen, John Shively, David Colcher, Amrita Krishnan and Flavia Pichiorri
  • Maintenance of murine platelet homeostasis by the kinase Csk and the phosphatase CD148
    Jun Mori, Zoltan Nagy, Giada Di Nunzio, Christopher W. Smith, Mitchell J. Geer, Rashid Al Ghaithi, Johanna P. van Geffen, Silke Heising, Luke Boothman, Bibian M. E. Tullemans, Joao N. Correia, Louise Tee, Marijke J. E. Kuijpers, Paul Harrison, Johan W. M. Heemskerk, Gavin E. Jarvis, Alexander Tarakhovsky, Arthur Weiss, Alexandra Mazharian and Yotis A. Senis

January 03, 2018

January 02, 2018

December 29, 2017

December 28, 2017

December 27, 2017

December 26, 2017

December 19, 2017

December 18, 2017

December 15, 2017

Pages